The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson’s Disease in Rats

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

Neuroinflammation in Alzheimer's disease

Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · see citing works

Epidemiology of Parkinson's disease

de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110 · see citing works

Parkin is recruited selectively to impaired mitochondria and promotes their autophagy

Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026 · see citing works

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849 · see citing works

Neurodegenerative Disorders: Parkinson's Disease and Huntington's Disease

Hague, S., Klaffke, S., & Bandmann, O. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781860948961_0007 · Cited by 2,767 · see citing works

Thioredoxin-interacting protein links oxidative stress to inflammasome activation

Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708 · see citing works

Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica

Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658 · see citing works

The NALP3 inflammasome is involved in the innate immune response to amyloid-β

Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441 · see citing works

Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis

Shimada, K., Crother, T. R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., Ramanujan, V. K., Wolf, A. J., Vergnes, L., Ojcius, D. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.009 · Cited by 2,282 · see citing works

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · see citing works

PINK1-Phosphorylated Mitofusin 2 Is a Parkin Receptor for Culling Damaged Mitochondria

Chen, Y., & Dorn, G. W. (2013) · Science · doi:10.1126/science.1231031 · Cited by 1,323 · see citing works

Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome

Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., & Zhou, R. (2015) · Cell · doi:10.1016/j.cell.2014.11.047 · Cited by 1,014 · see citing works

Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia

Kim, W., Mohney, R. P., Wilson, B. C., Jeohn, G., Liu, B., & Hong, J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 881 · see citing works

Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease

Lundblad, M., Andersson, M., Winkler, C., Kirik, D., Wierup, N., & Cenci, M. A. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01843.x · Cited by 664 · see citing works

Neuroinflammation in Parkinson's disease

Hirsch, E. C., Vyas, S., & Hunot, S. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70065-7 · Cited by 586 · see citing works

Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies

Codolo, G., Plotegher, N., Pozzobon, T., Brucale, M., Tessari, I., Bubacco, L., & de Bernard, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055375 · Cited by 585 · see citing works

Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats

Hargus, G., Cooper, O., Deleidi, M., Levy, A. E., Lee, K., Marlow, E. D., Yow, A., Soldner, F., Hockemeyer, D. F., Hallett, P. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010209107 · Cited by 480 · see citing works

A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses

Mayor, A., Martinon, F., Smedt, T. D., Pétrilli, V., & Tschopp, J. (2007) · Nature Immunology · doi:10.1038/ni1459 · Cited by 438 · see citing works

Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics

Irrcher, I., Aleyasin, H., Seifert, E. L., Hewitt, S. J., Chhabra, S., Phillips, M., Lutz, A. K., Rousseaux, M. W. C., Bevilacqua, L., Jahani‐Asl, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq288 · Cited by 386 · see citing works

Inflammasomes: current understanding and open questions

Bauernfeind, F. G., Ablasser, A., Bartok, E., Kim-Hellmuth, S., Schmid-Burgk, J. L., Cavlar, T., & Hornung, V. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0567-4 · Cited by 356 · see citing works

Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease

Gao, H.-M., Zhang, F., Zhou, H., Kam, W., Wilson, B., & Hong, J.-S. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1003013 · Cited by 355 · see citing works

Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease

Koprich, J. B., Reske-Nielsen, C., Mithal, P., & Isacson, O. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-8 · Cited by 355 · see citing works

Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson’s disease

Pott Godoy, M. C., Tarelli, R., Ferrari, C. C., Sarchi, M. I., & Pitossi, F. J. (2008) · Brain · doi:10.1093/brain/awn101 · Cited by 335 · see citing works

Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2

Mortiboys, H., Johansen, K. K., Aasly, J. O., & Bandmann, O. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ff9685 · Cited by 309 · see citing works

Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy

Demento, S. L., Eisenbarth, S. C., Foellmer, H. G., Platt, C., Caplan, M. J., Mark Saltzman, W., Mellman, I., Ledizet, M., Fikrig, E., Flavell, R. A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.034 · Cited by 290 · see citing works

Caspase inhibition reduces apoptosis and increases survival of nigral transplants

Schierle, G. S. K., Hansson, O., Leist, M., Nicotera, P., Widner, H., & Brundin, P. (1999) · Nature Medicine · doi:10.1038/4785 · Cited by 280 · see citing works

Interleukin-1 mediates Alzheimer and Lewy body pathologies

Griffin, W. S. T., Liu, L., Li, Y., Mrak, R. E., & Barger, S. W. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-5 · Cited by 262 · see citing works

Lipopolysaccharide-Induced IL-18 Secretion from Murine Kupffer Cells Independently of Myeloid Differentiation Factor 88 That Is Critically Involved in Induction of Production of IL-12 and IL-1β

Seki, E., Tsutsui, H., Nakano, H., Tsuji, N. M., Hoshino, K., Adachi, O., Adachi, K., Futatsugi‐Yumikura, S., Kuida, K., Takeuchi, O., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2651 · Cited by 231 · see citing works

Modulator Effects of Interleukin-1β and Tumor Necrosis Factor-α on AMPA-Induced Excitotoxicity in Mouse Organotypic Hippocampal Slice Cultures

Bernardino, L. I., Xapelli, S., Silva, A. P., Jakobsen, B., Poulsen, F. R., Oliveira, C. R., Vezzani, A., Malva, J. O., & Zimmer, J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1510-05.2005 · Cited by 224 · see citing works

Interleukin-1β impairs brain derived neurotrophic factor-induced signal transduction

Tong, L., Balazs, R., Soiampornkul, R., Thangnipon, W., & Cotman, C. W. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.027 · Cited by 222 · see citing works

Inflammasome signaling at the heart of central nervous system pathology

Chakraborty, S., Kaushik, D. K., Gupta, M., & Basu, A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22343 · Cited by 186 · see citing works

DJ-1 regulation of mitochondrial function and autophagy through oxidative stress

McCoy, M. K., & Cookson, M. (2011) · Autophagy · doi:10.4161/auto.7.5.14684 · Cited by 167 · see citing works

Interleukin-1 Receptor Antagonist: A New Therapy for Type 2 Diabetes Mellitus

Akash, M. S. H., Shen, Q., Rehman, K., & Chen, S. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23057 · Cited by 153 · see citing works

Neuroinflammation in the pathophysiology of Parkinson's disease: Evidence from animal models to human in vivo studies with [11C]‐PK11195 PET

Bartels, A. L., & Leenders, K. L. (2007) · Movement Disorders · doi:10.1002/mds.21552 · Cited by 127 · see citing works

Neuroinflammation and Peripheral Immune Infiltration in Parkinson's Disease: An Autoimmune Hypothesis

Monahan, A. J., Warren, M., & Carvey, P. M. (2008) · Cell Transplantation · doi:10.3727/096368908784423328 · Cited by 126 · see citing works

Activation of Nlrp3 Inflammasomes Enhances Macrophage Lipid-Deposition and Migration: Implication of a Novel Role of Inflammasome in Atherogenesis

Li, X., Zhang, Y., Xia, M., Gulbins, E., Boini, K. M., & Li, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087552 · Cited by 116 · see citing works

Further characterisation of the LPS model of Parkinson’s disease: A comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat

Hoban, D. B., Connaughton, E., Connaughton, C., Hogan, G., Thornton, C., Mulcahy, P. J., Moloney, T. C., & Dowd, E. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.10.001 · Cited by 113 · see citing works

Proinflammatory cytokines, IL-1β and TNF-α, induce expression of interleukin-34 mRNA via JNK- and p44/42 MAPK-NF-κB pathway but not p38 pathway in osteoblasts

Eda, H., Shimada, H., Beidler, D. R., & Monahan, J. B. (2010) · Rheumatology International · doi:10.1007/s00296-010-1688-7 · Cited by 103 · see citing works

Blocking Interleukin‐1 in Rheumatic Diseases

Goldbach‐Mansky, R. T. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05159.x · Cited by 96 · see citing works

Uncoupling protein 2 deficiency aggravates astrocytic endoplasmic reticulum stress and nod-like receptor protein 3 inflammasome activation

Lu, M., Sun, X., Qiao, C., Liu, Y., Ding, J., & Hu, G. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.015 · Cited by 91 · see citing works

In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6‐hydroxydopamine‐lesioned rats

Sarre, S., Yuan, H., Jonkers, N., Hemelrijck, A. V., Ebinger, G., & Michotte, Y. M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02471.x · Cited by 87 · see citing works

Inflammatory and Cell Death Pathways in Brain and Peripheral Blood in Parkinson’s Disease

Macchi, B., Paola, R. D., Marino‐Merlo, F., Felice, M. R., Cuzzocrea, S., & Mastino, A. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150225124928 · Cited by 80 · see citing works

The caspase-1 inhibitor AC-YVAD-CMK attenuates acute gastric injury in mice: involvement of silencing NLRP3 inflammasome activities

Zhang, F., Wang, L., Wang, J., Luo, P., Wang, X., & Xia, Z.-F. (2016) · Scientific Reports · doi:10.1038/srep24166 · Cited by 59 · see citing works

Inhibition of caspase-1 in rat brain reduces spontaneous nonrapid eye movement sleep and nonrapid eye movement sleep enhancement induced by lipopolysaccharide

Imeri, L., Bianchi, S., & Opp, M. R. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00828.2005 · Cited by 36 · see citing works

Role of Interleukin‐1 Inhibitors in the Management of Gout

Tran, T. H., Pham, J. T., Shafeeq, H., Manigault, K. R., & Arya, V. A. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1265 · Cited by 32 · see citing works

Chronic morphine potentiates the inflammatory response by disrupting interleukin-1β modulation of the hypothalamic–pituitary–adrenal axis

House, S. D. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00337-x · Cited by 31 · see citing works

Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice

Worlitzer, M. M. A., Bunk, E. C., Hemmer, K., & Schwamborn, J. C. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt124 · Cited by 21 · see citing works

Der Interleukin-1-Rezeptorantagonist Anakinra (Kineret�) in der Behandlung mit rheumatoider Arthritis

Rubbert-Roth, A., & Perniok, A. (2003) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-003-0545-4 · Cited by 9 · see citing works

RNAi-mediated silencing of HLA A2 suppressed acute rejection against human fibroblast xenografts in the striatum of 6-OHDA lesioned rats

Liang, C., Xu, Y., Zheng, D., Sun, X., Xu, Q., & Duan, D. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.05.002 · Cited by 5 · see citing works

The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology

Rutsch, A., Kantsjö, J. B., & Ronchi, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604179 · Cited by 821 · see citing works

Inflammasomes in neuroinflammatory and neurodegenerative diseases

Voet, S., Srinivasan, S., Lamkanfi, M., & van Loo, G. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201810248 · Cited by 761 · see citing works

The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease

Wang, S., Yuan, Y., Chen, N., & Wang, H. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.12.019 · Cited by 447 · see citing works

MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration

Lee, E., Hwang, I., Park, S., Hong, S., Hwang, B., Cho, Y., Son, J., & Yu, J.-W. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0124-5 · Cited by 431 · see citing works

Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities

Schmidt, M. F., Gan, Z. Y., Komander, D., & Dewson, G. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00706-7 · Cited by 373 · see citing works

Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis

Calabrese, V., Santoro, A., Monti, D., Crupi, R., Di Paola, R., Latteri, S., Cuzzocrea, S., Zappia, M., Giordano, J., Calabrese, E. J., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.379 · Cited by 356 · see citing works

Dopamine, Immunity, and Disease

Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J. R., & Gaskill, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 319 · see citing works

The IL-1β phenomena in neuroinflammatory diseases

Mendiola, A. S., & Cardona, A. E. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1732-9 · Cited by 311 · see citing works

NLRP3 inflammasome in neuroinflammation and central nervous system diseases

Xu, W. R., Huang, Y., & Zhou, R. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01275-w · Cited by 309 · see citing works

Targeting the Microglial NLRP3 Inflammasome and Its Role in Parkinson's Disease

Haque, M. E., Akther, M., Jakaria, M., Kim, I., Azam, S., & Choi, D. (2019) · Movement Disorders · doi:10.1002/mds.27874 · Cited by 248 · see citing works

The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease

Zhang, C., Zhao, M., Wang, B., Su, Z., Guo, B., Qin, L., Zhang, W., & Zheng, R. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102134 · Cited by 205 · see citing works

Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases

Wu, A., Zhou, X., Qiao, G., Yu, L., Tang, Y., Yan, L., Qiu, W., Pan, R., Yu, C., Law, B. Y. K., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101202 · Cited by 193 · see citing works

NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s disease

von Herrmann, K. M., Salas, L. A., Martinez, E. M., Young, A. L., Howard, J. M., Feldman, M. S., Christensen, B. C., Wilkins, O. M., Lee, S., Hickey, W. F., et al. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0061-5 · Cited by 185 · see citing works

Manganese activates NLRP3 inflammasome signaling and propagates exosomal release of ASC in microglial cells.

Sarkar, S., Rokad, D., Malovic, E., Luo, J., Harischandra, D. S., Jin, H., Anantharam, V., Huang, X., Lewis, M., Kanthasamy, A., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aat9900 · Cited by 171 · see citing works

Long Noncoding RNA SNHG1 Promotes Neuroinflammation in Parkinson’s Disease via Regulating miR-7/NLRP3 Pathway

Cao, B., Wang, T., Qu, Q., Kang, T., & Yang, Q. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.07.019 · Cited by 167 · see citing works

NLRP3 Deficiency Protects Against Intermittent Hypoxia-Induced Neuroinflammation and Mitochondrial ROS by Promoting the PINK1-Parkin Pathway of Mitophagy in a Murine Model of Sleep Apnea

Wu, X., Gong, L., Xie, L., Gu, W., Wang, X., Liu, Z., & Li, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.628168 · Cited by 165 · see citing works

LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson’s disease

Cai, L.-J., Tu, L., Huang, X.-M., Huang, J., Qiu, N., Xie, G., Liao, J.-X., Du, W., Zhang, Y., & Tian, J. (2020) · Molecular Brain · doi:10.1186/s13041-020-00656-8 · Cited by 156 · see citing works

Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases

Zhang, X., Xu, A., Lv, J., Zhang, Q., Ran, Y., Wei, C., & Wu, J. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111822 · Cited by 147 · see citing works

The immune system in Parkinson's disease: what we know so far

Roodveldt, C., Bernardino, L. I., Çakmak, Ö. Ö., Dragić, M., Fladmark, K. E., Ertan, S., Aktaş, B., Pita, C., Ciglar, L., Garraux, G., et al. (2024) · Brain · doi:10.1093/brain/awae177 · Cited by 148 · see citing works

Stress-induced NLRP3 inflammasome activation negatively regulates fear memory in mice

Dong, Y., Li, S., Lu, Y., Li, X., Liao, Y., Peng, Z., Li, Y., Hou, L., Yuan, Z., & Cheng, J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01842-0 · Cited by 146 · see citing works

Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia

Fan, Z., Liang, Z., Yang, H. M., Pan, Y., Zheng, Y., & Wang, X. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1036-x · Cited by 134 · see citing works

Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine

Jin, S., Zhang, L., & Wang, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115215 · Cited by 138 · see citing works

Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk

Paudel, Y. N., Angelopoulou, E., Piperi, C., Shaikh, M. F., & Othman, I. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104593 · Cited by 113 · see citing works

TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson’s Disease Mice and LPS-Induced BV2 Cells

Huang, P., Zhang, Z., Zhang, P., Feng, J., Xie, J., Zheng, Y., Liang, X., Zhu, B., Chen, Z., Feng, S., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03713-0 · Cited by 111 · see citing works

SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models

Kwon, O., Song, J., Yang, Y., Kim, S., Kim, J. Y., Seok, M., Hwang, I., Yu, J., Karmacharya, J., Maeng, H., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013076 · Cited by 110 · see citing works

A novel role of NLRP3-generated IL-1β in the acute-chronic transition of peripheral lipopolysaccharide-elicited neuroinflammation: implications for sepsis-associated neurodegeneration

Zhao, Z., Wang, Y., Zhou, R., Li, Y., Gao, Y., Tu, D., Wilson, B., Song, S., Feng, J., Hong, J.-S., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1728-5 · Cited by 109 · see citing works

Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?

Peggion, C., Calí, T., & Brini, M. (2024) · Antioxidants · doi:10.3390/antiox13020240 · Cited by 106 · see citing works

NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease

Han, Q.-Q., & Le, W. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01023-y · Cited by 91 · see citing works

Epigenetic Regulation of Neuroinflammation in Parkinson’s Disease

Rasheed, M., Liang, J., Wang, C., Deng, Y., & Chen, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094956 · Cited by 94 · see citing works

Neuroinflammation in Parkinson’s Disease – Putative Pathomechanisms and Targets for Disease-Modification

Grotemeyer, A., McFleder, R. L., Wu, J., Wischhusen, J., & Ip, C. W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.878771 · Cited by 91 · see citing works

Activation of NLRP3 Inflammasome Promotes Foam Cell Formation in Vascular Smooth Muscle Cells and Atherogenesis Via HMGB1

Wang, R., Wu, W., Li, W., Huang, S., Li, Z., Liu, R.-M., Shan, Z., Zhang, C., Li, W., & Wang, S. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008596 · Cited by 88 · see citing works

Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases

Guan, Y., & Han, F. (2020) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2020.00037 · Cited by 87 · see citing works

Evidence for the Role of Mitochondrial DNA Release in the Inflammatory Response in Neurological Disorders

Moya, G. E., Rivera, P. D., & Dittenhafer‐Reed, K. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137030 · Cited by 88 · see citing works

Role of NLRP3 Inflammasome in Parkinson’s Disease and Therapeutic Considerations

Nguyen, L. T. N., Nguyễn, H. Đ., Kim, Y. J., Nguyen, T. T., Lai, T. T., Lee, Y. K., Ma, H., & Kim, Y. E. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223290 · Cited by 87 · see citing works

Naringenin Produces Neuroprotection Against LPS-Induced Dopamine Neurotoxicity via the Inhibition of Microglial NLRP3 Inflammasome Activation

Chen, C., Wei, Y.-Z., He, X., Li, D., Wang, G., Li, J.-J., & Zhang, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00936 · Cited by 85 · see citing works

Microglial NLRP3 inflammasome activation in multiple sclerosis

(2020) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.08.007 · Cited by 83 · see citing works

Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases

Sonninen, T.-M., Goldsteins, G., Laham-Karam, N., Koıstınaho, J., & Lehtonen, Š. (2020) · Cells · doi:10.3390/cells9102183 · Cited by 84 · see citing works

MicroRNA‐190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP‐induced Parkinson's disease mouse model

Sun, Q., Wang, S., Chen, J., Cai, H., Huang, W., Zhang, Y., Wang, L., & Xing, Y. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28907 · Cited by 82 · see citing works

Neurovascular Inflammaging in Health and Disease

Mészáros, Á., Molnár, K., Nógrádi, B., Hernádi, Z., Nyúl‐Tóth, Á., Wilhelm, I., & Krizbai, I. A. (2020) · Cells · doi:10.3390/cells9071614 · Cited by 79 · see citing works

Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics

Cui, Y., Yu, H., Bu, Z., Wen, L., Yan, L.-L., & Feng, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.894298 · Cited by 79 · see citing works

Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson’s Disease Model

Huang, S., Liu, H., Lin, Y., Liu, M., Lǐ, Y., Mao, H., Zhang, Z., Zhang, Y., Ye, P., Ding, L., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.618787 · Cited by 76 · see citing works

Targeting NLRP3 inflammasome for neurodegenerative disorders

Yao, J., Wang, Z., Song, W., & Zhang, Y. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02239-0 · Cited by 75 · see citing works

PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target

Mogensen, F. L., Scafidi, A., Poli, A., & Michelucci, A. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02776-z · Cited by 74 · see citing works

Targeting Inflammasomes to Treat Neurological Diseases

Lünemann, J. D., Malhotra, S., Shinohara, M. L., Montalbán, X., & Comabella, M. (2021) · Annals of Neurology · doi:10.1002/ana.26158 · Cited by 73 · see citing works

The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases

Possemato, E., Barbera, L. L., Nobili, A., Krashia, P., & D’Amelio, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101907 · Cited by 75 · see citing works

α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β1–42-stimulated murine astrocytes

Ebrahimi, T., Rust, M. I., Kaiser, S., Slowik, A., Beyer, C., Koczulla, A. R., Schulz, J. B., Habib, P., & Bach, J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1319-x · Cited by 70 · see citing works

NLRP3 Inflammasomes in Parkinson’s disease and their Regulation by Parkin

Yan, Y., Fang, Y., Zheng, R., Pu, J., & Zhang, B. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.08.004 · Cited by 70 · see citing works

Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?

Armentero, M., Cerri, S., & Blandini, F. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00232 · Cited by 70 · see citing works

miR‐29c‐3p inhibits microglial NLRP3 inflammasome activation by targeting NFAT5 in Parkinson's disease

Wang, R., Li, Q., He, Y., Yang, Y., Ma, Q., & Li, C. (2020) · Genes to Cells · doi:10.1111/gtc.12764 · Cited by 64 · see citing works

NLRP3 inflammasome in health and disease (Review)

Wang, H., Ma, L., Su, W., Liu, Y., Xie, N., & Liu, J. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5489 · Cited by 67 · see citing works

Role of Microgliosis and NLRP3 Inflammasome in Parkinson’s Disease Pathogenesis and Therapy

de Araújo, F. M., Cuenca‐Bermejo, L., Fernández‐Villalba, E., Costa, S. L., da Silva, V. D. A., & Herrero, M. T. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-01027-6 · Cited by 61 · see citing works

Inhibiting NLRP3 inflammasome with MCC950 ameliorates perioperative neurocognitive disorders, suppressing neuroinflammation in the hippocampus in aged mice

Fu, Q., Li, J., Qiu, L., Ruan, J., Mao, M., Li, S., & Mao, Q.-H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106317 · Cited by 61 · see citing works

Microglia Pyroptosis: A Candidate Target for Neurological Diseases Treatment

Wu, X., Wan, T., Gao, X., Fu, M., Duan, Y., Shen, X., & Guo, W. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.922331 · Cited by 63 · see citing works

Long-term, West Nile virus-induced neurological changes: A comparison of patients and rodent models

Fulton, C. M., Beasley, D. W. C., Bente, D. A., & Dineley, K. T. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100105 · Cited by 58 · see citing works

Crosstalk Between the NLRP3 Inflammasome/ASC Speck and Amyloid Protein Aggregates Drives Disease Progression in Alzheimer’s and Parkinson’s Disease

Hulse, J. P., & Bhaskar, K. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.805169 · Cited by 60 · see citing works

NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors

Xu, Y., Yang, Y., Chen, X., Jiang, D., Zhang, F., Guo, Y., Hu, B., Xu, G., Peng, S., Wu, L., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00381-x · Cited by 62 · see citing works

NLRP3 Inflammasome Inhibition Prevents α-Synuclein Pathology by Relieving Autophagy Dysfunction in Chronic MPTP–Treated NLRP3 Knockout Mice

Ou, Z., Zhou, Y., Wang, L., Xue, L., Zheng, J., Chen, L., & Tong, Q. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02198-5 · Cited by 58 · see citing works

Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson’s disease model

Qiu, X., Wang, Q., Hou, L., Zhang, C., Wang, Q., & Zhao, X. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.05.008 · Cited by 58 · see citing works

The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases

Feng, Y.-S., Tan, Z., Wu, L., Dong, F., & Zhang, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111428 · Cited by 58 · see citing works

NLRP3 inflammasomes: A potential target to improve mitochondrial biogenesis in Parkinson's disease

Khot, M., Sood, A., Tryphena, K. P., Khan, S. S., Srivastava, S., Singh, S. B., & Khatri, D. K. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175300 · Cited by 55 · see citing works

Baicalin exerts neuroprotective actions by regulating the Nrf2-NLRP3 axis in toxin-induced models of Parkinson's disease

Huang, J., Zhang, X., Yang, X., Yv, Q., Ye, F., Chen, S., Cui, Y., Gu, L., Zhu, M., & Li, W. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110820 · Cited by 54 · see citing works

Therapeutic Role of Inflammasome Inhibitors in Neurodegenerative Disorders

Lahooti, B., Chhibber, T., Bagchi, S., Varahachalam, S. P., & Jayant, R. D. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.11.004 · Cited by 50 · see citing works

Role of the NLRP3 inflammasome in neurodegenerative diseases and therapeutic implications

Duan, Y., Kelley, N., & He, Y. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.272576 · Cited by 50 · see citing works

Antrodia camphorata polysaccharide resists 6‐OHDA‐induced dopaminergic neuronal damage by inhibiting ROS‐NLRP3 activation

Han, C., Shen, H., Yang, Y., Sheng, Y., Wang, J., Li, W., Zhou, X., Guo, L., Zhai, L., & Guan, Q. (2020) · Brain and Behavior · doi:10.1002/brb3.1824 · Cited by 49 · see citing works

Sleep Disruption Worsens Seizures: Neuroinflammation as a Potential Mechanistic Link

Bonilla‐Jaime, H., Zeleke, H., Rojas, A., & Espinosa‐García, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212531 · Cited by 49 · see citing works

SARS‐COV‐2 infection and Parkinson's disease: Possible links and perspectives

Al-Kuraishy, H. M., Al-Gareeb, A. I., Kaushik, A. K., Kujawska, M., Ahmed, E., & Batiha, G. E. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25171 · Cited by 46 · see citing works

Neuroprotective Effects of Safflower Flavonoid Extract in 6-Hydroxydopamine-Induced Model of Parkinson’s Disease May Be Related to its Anti-Inflammatory Action

Lei, H., Ren, R., Sun, Y. X., Zhang, K., Zhao, X. S., Ablat, N., & Pu, X. (2020) · Molecules · doi:10.3390/molecules25215206 · Cited by 46 · see citing works

Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases

Litwiniuk, A., Baranowska-Bik, A., Domańska, A., Kalisz, M., & Bik, W. (2021) · Pharmaceuticals · doi:10.3390/ph14121221 · Cited by 45 · see citing works

Through Reducing ROS Production, IL-10 Suppresses Caspase-1-Dependent IL-1β Maturation, thereby Preventing Chronic Neuroinflammation and Neurodegeneration

Gao, Y., Tu, D., Yang, R., Chu, C., Hong, J., & Gao, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020465 · Cited by 45 · see citing works

NLRP3 Inflammasome-Related Proteins Are Upregulated in the Putamen of Patients With Multiple System Atrophy

Li, F., Ayaki, T., Maki, T., Sawamoto, N., & Takahashi, R. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly090 · Cited by 44 · see citing works

Microglial NLRP3 Inflammasome Induces Excitatory Synaptic Loss Through IL-1β-Enriched Microvesicle Release: Implications for Sepsis-Associated Encephalopathy

Moraes, C. A., Hottz, E. D., Dos Santos Ornellas, D., Adesse, D., de Azevedo, C. T., d’Avila, J. C., Zaverucha-do-Valle, C., Maron-Gutierrez, T., Barbosa, H. S., Bozza, P. T., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03067-z · Cited by 43 · see citing works

Cigarette smoke-induced inflammation: NLRP10-mediated mechanisms

Kaur, G., Bagam, P., Pinkston, R., Singh, D. P., & Batra, S. (2018) · Toxicology · doi:10.1016/j.tox.2018.02.010 · Cited by 42 · see citing works

Inflammasomes in CNS Diseases

Albornoz, E. A., Woodruff, T. M., & Gordon, R. (2018) · Experientia supplementum · doi:10.1007/978-3-319-89390-7_3 · Cited by 42 · see citing works

Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis

Jiang, X., Wu, K., Ye, X., Xie, T., Zhang, P., Blass, B. E., & Bai, R. (2023) · Medicinal Research Reviews · doi:10.1002/med.21939 · Cited by 40 · see citing works

Suppression of Presymptomatic Oxidative Stress and Inflammation in Neurodegeneration by Grape-Derived Polyphenols

Herman, F. J., Westfall, S., Brathwaite, J. S., & Pasinetti, G. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00867 · Cited by 40 · see citing works

MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis

Datta, N., Johnson, C., Kao, D. H., Gurnani, P., Alexander, C., Polytarchou, C., & Monaghan, T. M. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106870 · Cited by 39 · see citing works

NLRP3 Inflammasome Blockade Reduces Cocaine-Induced Microglial Activation and Neuroinflammation

Chivero, E. T., Thangaraj, A., Tripathi, A., Periyasamy, P., Guo, M., & Buch, S. J. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02184-x · Cited by 39 · see citing works

The “mitochondrial stress responses”: the “Dr. Jekyll and Mr. Hyde” of neuronal disorders

Rimessi, A., Patergnani, S., Morciano, G., Carinci, M., Leo, S., & Pinton, P. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.339473 · Cited by 39 · see citing works

Cerebrovascular inflammation: A critical trigger for neurovascular injury?

Naveed, M., Zhou, Q., & Han, F. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.03.011 · Cited by 36 · see citing works

Down-regulation of DJ-1 Augments Neuroinflammation via Nrf2/Trx1/NLRP3 Axis in MPTP-induced Parkinson’s Disease Mouse Model

Ji, Y.-J., Wang, H., Yin, B.-L., & Ren, X. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.06.001 · Cited by 38 · see citing works

Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases

Akter, R., Rahman, H., Behl, T., Chowdhury, M. A. R., Manirujjaman, M., Bulbul, I. J., Elshenawy, S. E., Ţiţ, D. M., & BUNGAU, S. G. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210218084444 · Cited by 38 · see citing works

The Potential of NLRP3 Inflammasome as a Therapeutic Target in Neurological Diseases

He, W., Hu, Z., Zhong, Y., Wu, C., & Li, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03229-7 · Cited by 36 · see citing works

Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection

Pirooznia, S. K., Rosenthal, L. S., Dawson, V. L., & Dawson, T. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000189 · Cited by 36 · see citing works

The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain

Maran, J. J., Adesina, M. M., Green, C. R., Kwakowsky, A., & Mugisho, O. O. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101954 · Cited by 36 · see citing works

BAG3 promotes autophagy and suppresses NLRP3 inflammasome activation in Parkinson’s disease

Ying, Z.-M., Lv, Q.-K., Yao, X., Dong, A.-Q., Yang, Y., Cao, Y.-L., Wang, F., Ai-ping, G., & Liu, C. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-5159 · Cited by 34 · see citing works

Gut–Brain Axis: Focus on Sex Differences in Neuroinflammation

Caldarelli, M., Rio, P., Marrone, A., Ocarino, F., Chiantore, M., Candelli, M., Gasbarrini, A., Gambassi, G., & Cianci, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105377 · Cited by 36 · see citing works

Neuroinflammation in Age-Related Neurodegenerative Diseases: Role of Mitochondrial Oxidative Stress

Abadin, X., de Dios, C., Zubillaga, M., Ivars, E., Puigròs, M., Marı́, M., Morales, A., Vizuete, M., Vitórica, J., Trullás, R., et al. (2024) · Antioxidants · doi:10.3390/antiox13121440 · Cited by 35 · see citing works

Inhibition of Long Non-Coding RNA KCNQ1OT1 Attenuates Neuroinflammation and Neuronal Apoptosis Through Regulating NLRP3 Expression via Sponging miR-30e-3p

Song, A., Yang, Y., He, H., Sun, J., Chang, Q., & Xue, Q. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s291274 · Cited by 33 · see citing works

Neuroprotective effects of natural cordycepin on LPS-induced Parkinson’s disease through suppressing TLR4/NF-κB/NLRP3-mediated pyroptosis

Sun, Y. J., Huang, W.-M., Tang, P.-C., Zhang, X., Zhang, X.-Y., Yu, B.-C., Fan, Y. M., Ge, X., & Zhang, X. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104274 · Cited by 33 · see citing works

Perillyl Alcohol Attenuates NLRP3 Inflammasome Activation and Rescues Dopaminergic Neurons in Experimental In Vitro and In Vivo Models of Parkinson’s Disease

Ahmed, S., Panda, S. R., Kwatra, M., Sahu, B. D., & Naidu, V. G. M. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00550 · Cited by 33 · see citing works

Quercetin Alleviated Inflammasome-Mediated Pyroptosis and Modulated the mTOR/P70S6/P6/eIF4E/4EBP1 Pathway in Ischemic Stroke

Alattar, A., Alshaman, R., Althobaiti, Y. S., Soliman, G. M., Ali, H. S., Khubrni, W. S., Koh, P., Rehman, N. U., & Shah, F. A. (2023) · Pharmaceuticals · doi:10.3390/ph16081182 · Cited by 31 · see citing works

Short-Chain Fatty Acid Aggregates Alpha-Synuclein Accumulation and Neuroinflammation via GPR43-NLRP3 Signaling Pathway in a Model Parkinson’s Disease

Qu, Y., An, K., Wang, D., Yu, H., Li, J., Min, Z., Xiong, Y., Xue, Z., & Mao, Z. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04726-7 · Cited by 30 · see citing works

The role and therapeutic potential of connexins, pannexins and their channels in Parkinson's disease

Ahmadian, E., Eftekhari, A., Samiei, M., Dizaj, S. M., & Vinken, M. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.03.010 · Cited by 30 · see citing works

Molecular mechanisms of cordycepin emphasizing its potential against neuroinflammation: An update

Govindula, A., Pai, A., Baghel, S. S., & Mudgal, J. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174364 · Cited by 30 · see citing works

Heat‐killed Lactobacillus murinus confers neuroprotection against dopamine neuronal loss by targeting NLRP3 inflammasome

Fan, H., Sheng, S., Li, D., Li, J., Wang, G., & Zhang, F. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10455 · Cited by 30 · see citing works

Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson’s disease

Redenšek, S., Flisar, D., Kojović, M., Kramberger, M. G., Georgiev, D., Pirtošek, Z., Trošt, M., & Dolžan, V. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1439-y · Cited by 29 · see citing works

Anti-neuroinflammatory effects of dimethylaminomylide (DMAMCL, i.e., ACT001) are associated with attenuating the NLRP3 inflammasome in MPTP-induced Parkinson disease in mice

Liu, Q., Guo, X., Huang, Z., He, Q., Zhu, D., Zhang, S., Peng, Z., Che, Y., & Feng, X. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112539 · Cited by 28 · see citing works

The mechanism behind activation of the Nod-like receptor family protein 3 inflammasome in Parkinson’s disease

Xie, A., Wang, J., Zhang, X., Fang, J.-N., Hua, F.-F., Han, J.-Y., & Yuan, Z. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.323077 · Cited by 28 · see citing works

Bushen‐Yizhi Formula Alleviates Neuroinflammation via Inhibiting NLRP3 Inflammasome Activation in a Mouse Model of Parkinson’s Disease

Mo, Y., Xu, E., Wei, R., Le, B., Song, L., Li, D., Chen, Y., Ji, X., Fang, S., Shen, J., et al. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/3571604 · Cited by 27 · see citing works

Sirtuin dysregulation in Parkinson's disease: Implications of acetylation and deacetylation processes

Dhiman, S., Mannan, A., Taneja, A., Mohan, M., & Singh, T. G. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122537 · Cited by 25 · see citing works

A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease

Huang, S., Chen, Z., Fan, B., Chen, Y., Zhou, L., Jiang, B., Long, H., Zhong, W., Li, X., & Li, Y. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577543 · Cited by 80 · see citing works

Advances in the study of the nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome in Parkinson′s disease

Zhang, Z., Li, Y., & Zhang, Y. (2020) · Chin J Neurol · doi:10.3760/cma.j.issn.1006-7876.2020.02.014

Role of NLRP3 in Parkinson's disease: Specific activation especially in dopaminergic neurons

Yu, J., Zhao, Z., Li, Y., Chen, J., Huang, N., & Luo, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28838 · Cited by 30 · see citing works

Inhibition of NLRP3 inflammasome ameliorates LPS-induced neuroinflammatory injury in mice via PINK1/Parkin pathway

Wang, A., Zhong, G., Ying, M., Fang, Z., Chen, Y., Wang, H., Wang, C., Liu, C., & Guo, Y. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110063 · Cited by 24 · see citing works

Targeting the NLRP3 inflammasome in Parkinson's disease: From molecular mechanism to therapeutic strategy

Liang, J.-Y., Yuan, X., Jiang, J., Zhang, P., & Kuang-Tan (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115167 · Cited by 9 · see citing works